Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Revive Therapeutics names kidney expert as scientific officer

Wednesday, March 8, 2017 7:41
% of readers think this story is Fact. Add your two cents.

Drug developer Revive Therapeutics Ltd told investors that specialist Dr Yanlin Wang will become a scientific advisor to the firm on cannabinoid-based therapeutics, which target kidney diseases.

The biotech is investigating the potential of drugs and plant-based therapies, such as cannabinoids, that may be repurposed for new indications.

Wang is an associate professor of medicine and a director of basic research at the Selzman Institute for Kidney Health and Section of Nephrology of the Department of Medicine at Baylor College of Medicine.

He is also a Fellow of the American Society of Nephrology, as well as an active clinician.

Craig Leon, chief executive of Revive, said: “Dr. Wang has experience with a number of research kidney models that will help to advance developments to the clinic and he will be instrumental in assisting Revive’s initiatives in the product and clinical development of cannabinoid-based therapeutics for kidney diseases.”

Story by ProactiveInvestors


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.